1 / 8

Pre-Eclampsia - Pipeline Review, H2 2014 market analysis

To Get More Info. Visit: http://www.analyzefuture.com/pre-eclampsia-pipeline-review-h2-2014-market Pre-Eclampsia - Pipeline Review, H2 2014 Global Markets Direct’s, ‘Pre-Eclampsia - Pipeline Review, H2 2014’, provides an overview of the Pre-Eclampsia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pre-Eclampsia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pre-Eclampsia and special features on late-stage and discontinued projects.

joseph_gentile
Download Presentation

Pre-Eclampsia - Pipeline Review, H2 2014 market analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pre-Eclampsia - Pipeline Review, H2 2014 No. Pages : 50 Published on : Dec-2014

  2. Report Description Pre-Eclampsia - Pipeline Review, H2 2014 Global Markets Direct’s, ‘Pre-Eclampsia - Pipeline Review, H2 2014’, provides an overview of the Pre-Eclampsia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pre-Eclampsia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pre-Eclampsia and special features on late-stage and discontinued projects. To Get More Info. Visit : http://www.analyzefuture.com/pre-eclampsia-pipeline-review-h2-2014-market

  3. Report Description Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. To Enquire About Report @ http://www.analyzefuture.com/pre-eclampsia-pipeline-review-h2-2014-market/report-enquiry The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

  4. Table of Content Table Of ContentsTable of ContentsTable of Contents 2List of Tables 4List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Pre-Eclampsia Overview 6Therapeutics Development 7Pipeline Products for Pre-Eclampsia - Overview 7Pipeline Products for Pre-Eclampsia - Comparative Analysis 8Pre-Eclampsia - Therapeutics under Development by Companies 9Pre-Eclampsia - Therapeutics under Investigation by Universities/Institutes 10Pre-Eclampsia - Pipeline Products Glance 11Late Stage Products 11Clinical Stage Products 12Early Stage Products 13

  5. Table of Content Pre-Eclampsia - Products under Development by Companies 14Pre-Eclampsia - Products under Investigation by Universities/Institutes 15Pre-Eclampsia - Companies Involved in Therapeutics Development 16A1M Pharma AB 16Alnylam Pharmaceuticals, Inc. 17Glenveigh Medical, LLC 18Pluristem Therapeutics Inc. 19rEVO Biologics 20VG Life Sciences, Inc. 21Pre-Eclampsia - Therapeutics Assessment 22Assessment by Monotherapy Products 22Assessment by Target 23Assessment by Mechanism of Action 25Assessment by Route of Administration 27Assessment by Molecule Type 29Drug Profiles 31

  6. Table of Content ALN-AGT - Drug Profile 31Product Description 31Mechanism of Action 31R&D Progress 31Alpha-1-Microglobulin - Drug Profile 32Product Description 32Mechanism of Action 32R&D Progress 32antithrombinalfa (recombinant) - Drug Profile 33Product Description 33Mechanism of Action 33R&D Progress 33digoxin immune fab - Drug Profile 34Product Description 34Mechanism of Action 34R&D Progress 34Monoclonal Antibodies for Cardiovascular Diseases - Drug Profile 35

  7. Table of Content Product Description 35Mechanism of Action 35R&D Progress 35Peptide to Activate G Protein-Coupled Receptor Mas for Cardiovascular, Metabolic Disorders and Erectile Dysfunction - Drug Profile 36Product Description 36Mechanism of Action 36R&D Progress 36Stem Cell Therapy for Pre-Eclampsia - Drug Profile 37Product Description 37Mechanism of Action 37R&D Progress 37VG-1177 - Drug Profile 38Product Description 38Mechanism of Action 38R&D Progress 38Pre-Eclampsia - Recent Pipeline Updates 40 To Get Complete TOC Visit at: http://www.analyzefuture.com/pre-eclampsia-pipeline-review-h2-2014-market/table-of-contents Upcoming Reports : http://www.analyzefuture.com/nerve-repair-regeneration-market

  8. FOR MORE DETAILS Visit us at : http://www.analyzefuture.com/ Stay With Us: 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States. TELEPHONE: +1 (855) 711-1555 EMAIL: sales@analyzefuture.com

More Related